Published in J Exp Med on August 01, 1990
Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J Exp Med (1999) 1.31
Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun (2002) 1.30
Adoptive transfer of neonatal T lymphocytes rescues immunoglobulin production in mice with severe combined immune deficiency. J Exp Med (1991) 1.23
Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation. J Exp Med (1993) 0.92
CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools. Proc Natl Acad Sci U S A (2000) 0.88
Ability of spleen, peritoneal cavity, and lymph node B cells to reconstitute serum immunoglobulin in SCID mice. Immunology (1996) 0.85
Rapid restoration of B-cell function in XID mice by intravenous transfer of peritoneal cavity B cells. Immunology (1994) 0.84
Recipient age determines the success of intraperitoneal transplantation of peritoneal cavity B cells. Immunology (1997) 0.79
CD3+ T cells in severe combined immunodeficiency (scid) mice. VI. Rescue of scid-derived, IgM-producing B cells by transfer of CD4+ CD8- T cells from various lymphoid organs. Immunology (1992) 0.78
DBA/2J (Mls-1a) B-cell differentiation in BALB.xid recipients. Immunology (2000) 0.75
Increased serum IgG1 levels and reduced numbers of B-1 B cells in DBA/2J mice. Immunology (1998) 0.75
Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol (1978) 13.40
Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 5.15
Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry (1972) 4.26
Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol (1985) 3.69
Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol (1987) 2.60
Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies. J Immunol (1984) 2.16
Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol (1975) 1.68
Feedback regulation of murine Ly-1 B cell development. Eur J Immunol (1989) 1.53
Novel V genes encode virtually identical variable regions of six murine monoclonal anti-bromelain-treated red blood cell autoantibodies. J Immunol (1987) 1.33
Cell surface antigen CD5 is a marker for activated human B cells. Eur J Immunol (1989) 1.12
Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells. Eur J Immunol (1989) 1.06
Abnormalities in isotype expression in CBA/N mice due to stimulatory environment rather than a B cell defect. J Immunol (1983) 1.01
Establishment and functional implications of B-cell connectivity. Immunol Rev (1989) 0.99
In vivo effects of hyperdiploid Ly-1+ B cells of NZB origin. J Immunol (1988) 0.91
Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors. J Immunol (1987) 0.82
A requirement for two cell types for antibody formation in vitro. Science (1967) 8.91
Cell interactions in the primary immune response in vitro: a requirement for specific cell clusters. J Exp Med (1969) 3.38
Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science (1999) 3.10
Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J Exp Med (1985) 2.87
Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J Exp Med (1978) 2.86
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity (1999) 2.67
Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50
Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes. J Exp Med (1975) 2.49
Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med (1977) 2.18
T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur J Immunol (1978) 2.13
The rate of division of antibody-forming cells during the early primary immune response. J Exp Med (1968) 2.10
Cellular requirements for the primary in vitro antibody response to DNP-ficoll. J Exp Med (1974) 2.10
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med (1988) 2.06
The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J Immunol (1977) 2.03
Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J Virol (2006) 2.00
Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J Exp Med (1987) 2.00
Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice. J Exp Med (1978) 1.89
Mice whose B cells cannot produce the T15 idiotype also lack an antigen-specific helper T cell required for T15 expression. J Exp Med (1979) 1.86
In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide. J Immunol (1976) 1.86
Functional maturation of thymic lymphocyte populations in vitro. J Exp Med (1972) 1.76
Absence of an antigen-specific helper T cell required for the expression of the T 15 idiotype in mice treated with anti-mu antibody. Eur J Immunol (1980) 1.62
Primary in vitro antibody responses by purified murine B lymphocytes in serum-free defined medium. J Immunol (1981) 1.61
Cellular deficit in thymectomized mice. Nature (1970) 1.57
Pneumococcal polysaccharides induce antibody formation by human B lymphocytes in vitro. J Immunol (1985) 1.55
Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. Proc Natl Acad Sci U S A (1998) 1.50
In vitro studies of the genetically determined unresponsiveness to thymus-independent antigens in CBA/N mice. J Immunol (1976) 1.50
The role of surface IgD in the response to thymic-independent antigens. J Exp Med (1977) 1.46
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locus. J Immunol (1979) 1.43
Ontogeny of mouse lymphocyte function. I. Paradoxical elevation of reactivity to allogeneic cells and phytohemagglutinin in BALB-c fetal thymocytes. J Immunol (1974) 1.39
Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes. J Exp Med (1978) 1.37
Animal models for retrovirus-induced immunodeficiency disease. Immunol Invest (1986) 1.34
Ly phenotype and mechanism of action of mouse neonatal suppressor T cells. J Exp Med (1977) 1.33
hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunol Rev (1991) 1.29
Mitochondria are redistributed in Drosophila photoreceptors lacking milton, a kinesin-associated protein. J Comp Neurol (2003) 1.28
Adoptive transfer of neonatal T lymphocytes rescues immunoglobulin production in mice with severe combined immune deficiency. J Exp Med (1991) 1.23
Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens. J Exp Med (1979) 1.19
Macrophage requirement for the in vitro response to TNP Ficoll: a thymic independent antigen. J Immunol (1976) 1.19
HIV results in the frame. CD4+ cell turnover. Nature (1995) 1.19
The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. J Virol (1998) 1.15
Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression. J Virol (2001) 1.15
Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol (1990) 1.14
Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody. J Immunol (1983) 1.11
Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies. J Exp Med (1984) 1.04
Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. J Virol (2009) 1.02
Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine. J Immunol (1988) 1.01
Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol (1997) 1.01
Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol (1989) 1.01
Immunologic effects of neonatal infection with mouse thymic virus. J Immunol (1975) 1.00
Formation of antibody in the newborn mouse: study of T-cell-independent antibody response. J Infect Dis (1977) 1.00
Lyb antigens and their role in B lymphocyte activation. Immunol Rev (1982) 0.99
The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. J Immunol (1999) 0.98
Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. Cancer Res (1992) 0.97
Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice. J Virol (1997) 0.97
On the SCIDs? Nature (1989) 0.95
Cell-cell interactions in antibody production. Prog Allergy (1972) 0.95
The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology (1997) 0.94
Induction of B cell priming by neonatal injection of mice with thymic-independent (type 2) antigens. J Immunol (1978) 0.93
LP-BM5 murine retrovirus-induced immunodeficiency disease in allogeneic SCID chimeric mice. Inability to recognize a putative viral superantigen does not prevent induction of disease. J Immunol (1993) 0.93
Separation of macrophages on plastic and glass surfaces. Methods Enzymol (1984) 0.92
Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist. J Immunol (1996) 0.92
The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes. J Virol (1996) 0.92
Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J Virol (1995) 0.91
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy. J Acquir Immune Defic Syndr (2000) 0.90
Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice. J Virol (1997) 0.90
Lyb-8.2: A new B cell antigen defined and characterized with a monoclonal antibody. Immunogenetics (1982) 0.90
CD4+CD8- thymocytes from neonatal mice induce IgM production in SCID mice. J Immunol (1992) 0.89
Ontogeny of mouse T-lymphocyte function. Fed Proc (1975) 0.89
Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. J Virol (1992) 0.87
Early modification of host cell gene expression induced by HIV-1. AIDS (1998) 0.86
Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency. Leuk Res (1992) 0.85
Effective therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate. AIDS Res Hum Retroviruses (1991) 0.84
Interaction of helper T cells and Lyb5+ B cells responding to phosphorylcholine is MHC-restricted. J Exp Med (1984) 0.84
Reactivity of steroid-resistant neonatal thymocytes. Nature (1974) 0.84
Cellular requirements for antigen presentation in the induction of a thymus-independent antibody response in vitro. J Immunol (1980) 0.83
Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J Immunol (1994) 0.83
Maturation of reactivity to histocompatibility antigens. Transplant Proc (1972) 0.83
Immunobiology of Epstein-Barr virus-associated lymphomas. Clin Immunol Immunopathol (1994) 0.82
CD4+ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. J Immunol (1997) 0.82
Negative selection in vivo reveals expression of strong Mls determinants in mice with X-linked immunodeficiency. J Exp Med (1984) 0.82
Antigen-specific helper T cells required for dominant idiotype expression are not H-2 restricted. J Exp Med (1981) 0.81
Cell cooperation during in vivo anti-hapten antibody responses. VI. Evidence for an allogeneic effect replacing one of two helper T cells. Eur J Immunol (1980) 0.81
Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice. J Interferon Cytokine Res (1999) 0.80
Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells. AIDS Res Hum Retroviruses (1994) 0.79
Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donors. Cancer Res (1992) 0.79
Ontogeny of in vitro correlates of graft-versus-host reactions. Transplant Proc (1976) 0.79
Transient appearance of PHA-reactive thymocytes in the foetal mouse. Nat New Biol (1973) 0.79
Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines. Virology (1995) 0.78
Dose response and timing effects in the therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate. Int J Immunopharmacol (1993) 0.78
Helper T lymphocytes from xid and normal mice support anti-phosphocholine antibody responses with equivalent T15, 511, and 603 idiotypic composition. J Immunol (1984) 0.77
T cell activation of antigen-specific antibody responses by large B cells is MHC restricted. J Immunol (1986) 0.77
VH11 bias and normal V-D-J junctions in SCID B lymphocytes rescued by neonatal T cell transfer. Mol Immunol (1994) 0.77
Does preferential Th subset activation contribute to the murine acquired immunodeficiency disease (MAIDS)? Res Immunol (1995) 0.77
Break for SCIDs. Nature (1991) 0.77
Induction and rapid expression of an immune response in vitro. Nature (1968) 0.77
Ontogeny of susceptibility of mouse splenic B cells to tolerance induction in vitro by TNP-D-GL. Eur J Immunol (1979) 0.77
Biological activity of diethyldithiocarbamate (Ditiocarb, Imuthiol) in an animal model of retrovirus-induced immunodeficiency disease and in clinical trials in patients with HIV infection. The Ditiocarb Study Group. Dev Biol Stand (1990) 0.75
Development of the EMCS hardware for multigenerational growth of Drosophila melanogaster in space. Gravit Space Biol Bull (2005) 0.75